Choosing between the diversified stability of Johnson & Johnson ( JNJ -0. 36% ) and the rapid growth trajectory of Eli Lilly & Co ( LLY +0. 57% ) is a primary consideration for many healthcare investors in 2026.
Read the original report for the complete account of this story.